NCT03451981

Brief Summary

Peri-implantitis is an important disease entity as a result of its high prevalence and the lack of a standard mode of therapy. Non-surgical therapy of peri-implant disease, especially when bone loss is not high, appears to be partially effective in resolving the disease. In several cases, however, only limited improvements have been reported in the main clinical parameters (bleeding at the survey and presence of the pocket) and there is a clear tendency to relapse of the disease. In these cases it is therefore recommended to consider adjunctive therapies. Numerous approaches have been used for implant surface decontamination including mechanical, chemical and treatments by means of air-powder or laser. The aim of the present randomized controlled clinical trial will be to assess the efficacy in improving clinical parameters of two further methods of implant surface decontamination (Er:YAG laser or air-abrasive device) after mechanical cleaning during non surgical treatment of peri-implantitis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 20, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 2, 2018

Completed
9 months until next milestone

Study Start

First participant enrolled

December 2, 2018

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 6, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 6, 2021

Completed
Last Updated

December 29, 2025

Status Verified

December 1, 2025

Enrollment Period

2.8 years

First QC Date

February 20, 2018

Last Update Submit

December 21, 2025

Conditions

Keywords

non surgical therapylaserair powder

Outcome Measures

Primary Outcomes (1)

  • probing pocket depth changes

    changes in probing pocket depth, measured from the mucosal margin to the bottom of the pocket

    baseline, 1, 3, 6 months

Secondary Outcomes (2)

  • Bleeding on probing changes

    baseline,1, 3, 6 months

  • endpoint of therapy

    1,3,6 months

Study Arms (3)

Mechanical instrumentation with curettes

SHAM COMPARATOR

mechanical instrumentation: Inflammatory tissue, excess cement or plaque deposits will be removed using hand instruments (titanium curettes) and the implant surface will be cleaned.

Procedure: mechanical instrumentation

Er:YAG laser

EXPERIMENTAL

Er:YAG laser treatment will be provided on the implant surface.

Procedure: mechanical instrumentationProcedure: Er:YAG laser

Air Powder

ACTIVE COMPARATOR

an Air-Powder treatment will be provided on the implant surface.

Procedure: mechanical instrumentationProcedure: Air Powder

Interventions

Er:YAG laserPROCEDURE

mechanical debridement: Inflammatory tissue, excess cement or plaque deposits will be removed using hand instruments (titanium curettes) and the implant surface will be cleaned. Furthermore, Er:YAG laser treatment will be provided on the implant surface.

Er:YAG laser
Air PowderPROCEDURE

mechanical debridement: Inflammatory tissue, excess cement or plaque deposits will be removed using hand instruments (titanium curettes) and the implant surface will be cleaned. Furthermore, an Air-Powder treatment will be provided on the implant surface.

Air Powder

mechanical debridement: Inflammatory tissue, excess cement or plaque deposits will be removed using hand instruments (titanium curettes) and the implant surface will be cleaned

Also known as: titanium curettes
Air PowderEr:YAG laserMechanical instrumentation with curettes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • presence of at least one screw-type titanium implant exhibiting bleeding and/or suppuration on probing combined with:
  • a PPD ≥ 5 mm and bone loss \> 2 mm (compared to crestal bone levels at the time of placement of the reconstruction)
  • a PPD ≥ 6 mm and bone loss ≥ 3 mm (not compared to crestal bone levels at the time of placement of the reconstruction)
  • single tooth and bridgework restorations without overhangings
  • no evidence of occlusal overload (i.e. occlusal contacts revealed appropriate adjustment)
  • implant function time ≥ 1 year.

You may not qualify if:

  • Patients with uncontrolled diabetes,
  • patients with osteoporosis or under bisphosphonate medication,
  • pregnant or lactating women,
  • patients with a history of radiotherapy to the head and neck region
  • patients with incapability to perform basal oral hygiene measures due to physical or mental disorders
  • hollow implants
  • implant mobility
  • implants at which no position could be identified where proper probing measurements could be performed;
  • previous surgical treatment of the peri-implantitis lesions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Università Vita-Salute San Raffaele

Milan, Milano, 20100, Italy

Location

MeSH Terms

Conditions

Peri-Implantitis

Interventions

Lasers, Solid-State

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

LasersOptical DevicesEquipment and SuppliesRadiation Equipment and Supplies

Study Officials

  • Massimo De Sanctis, Prof.

    University Vita Salute San Raffaele

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 20, 2018

First Posted

March 2, 2018

Study Start

December 2, 2018

Primary Completion

October 6, 2021

Study Completion

October 6, 2021

Last Updated

December 29, 2025

Record last verified: 2025-12

Locations